OTC Pharmaceuticals - G7

  • G7
  • Revenue in the OTC Pharmaceuticals market amounts to US$76.83bn in 2024. The market is expected to grow annually by 3.50% (CAGR 2024-2029).
  • The market's largest segment is the segment Other OTC Pharmaceuticals with a market volume of US$17.66bn in 2024.
  • In global comparison, most revenue is generated in the United States (US$41,240m in 2024).
  • In relation to total population figures, per person revenues of US$98.70 are generated in 2024.
  • In the OTC Pharmaceuticals market, 28.9% of total revenue will be generated through online sales by 2024.

Key regions: Worldwide, India, Philippines, United States, Europe

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The OTC Pharmaceuticals market in G7 countries is experiencing steady growth due to changing customer preferences, emerging trends in the market, and local special circumstances. Customer preferences in the OTC Pharmaceuticals market have shifted towards self-medication and convenience.

Consumers are increasingly seeking over-the-counter medications for minor ailments and common health issues, as they provide a quick and easy solution without the need for a doctor's prescription. This preference for self-medication is driven by the desire for convenience and cost-effectiveness. Additionally, the aging population in G7 countries has contributed to the growth of the OTC Pharmaceuticals market, as older individuals often require medications for chronic conditions that can be managed with over-the-counter products.

Trends in the market are also driving the growth of the OTC Pharmaceuticals market in G7 countries. One notable trend is the increasing popularity of natural and herbal remedies. Consumers are becoming more conscious of their health and are seeking alternative treatments that are perceived as more natural and holistic.

This trend has led to the emergence of a wide range of herbal and natural OTC Pharmaceuticals products in the market. Another trend is the growing focus on preventive healthcare. Consumers are proactively seeking OTC Pharmaceuticals products that can help them maintain their health and prevent the onset of illnesses.

This trend is particularly prevalent among younger consumers who prioritize wellness and preventive measures. Local special circumstances in G7 countries are also contributing to the growth of the OTC Pharmaceuticals market. One such circumstance is the well-established healthcare infrastructure in these countries.

G7 countries have robust healthcare systems that provide access to quality healthcare services. This, coupled with high levels of health literacy among the population, has created a conducive environment for the growth of the OTC Pharmaceuticals market. Additionally, the regulatory environment in G7 countries is supportive of the OTC Pharmaceuticals market.

These countries have well-defined regulations that ensure the safety and efficacy of over-the-counter medications, giving consumers confidence in purchasing and using these products. Underlying macroeconomic factors are also driving the growth of the OTC Pharmaceuticals market in G7 countries. The strong economic growth in these countries has increased disposable incomes, allowing consumers to spend more on healthcare and wellness products.

Additionally, the rising healthcare costs and increasing burden on healthcare systems have led to a shift towards self-medication and the use of over-the-counter medications as a cost-effective alternative. The favorable economic conditions in G7 countries have created a conducive environment for the growth of the OTC Pharmaceuticals market. In conclusion, the OTC Pharmaceuticals market in G7 countries is experiencing steady growth due to changing customer preferences, emerging trends in the market, local special circumstances, and underlying macroeconomic factors.

The preference for self-medication, the emergence of natural and herbal remedies, and the focus on preventive healthcare are driving the growth of the market. The well-established healthcare infrastructure, supportive regulatory environment, and strong economic conditions in G7 countries further contribute to the growth of the OTC Pharmaceuticals market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Key Players
  • Analyst Opinion
  • Sales Channels
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)